The much-anticipated results of TauRx's Phase III trial for Alzheimer's disease have finally been disclosed. Despite some complicated effects, this could be…
Takeda Cambridge (the UK subsidiary of global biotech Takeda Pharmaceuticals) will now collaborate with University College London's Institute for Neurology…